For full video series on Renal Cell Carcinoma: https://wb.md/2T9THhF

Two noted oncologists bring current clinical evidence and their extensive clinical experience to the conundrum surrounding the management of metastatic renal cell carcinoma. The wealth of agents available for firstline, secondline, and thirdline therapy, coupled with the lack of evidence supporting one therapy over another, has left oncologists facing an empiric treatment process.

Dr Brian Rini, from the Cleveland Clinic, and Dr Nicholas Vogelzang, from the Comprehensive Cancer Centers of Nevada, sort through the complexity of issues and offer oncologists practical guidance in managing patients with this devastating disease.